Percentage of CD56+ monocytes at neutrophil engraftment is associated with the incidence of acute graft-versus-host disease [0.03%]
共刺激分子CD56＋单核细胞在中性粒细胞植入时的比例与急性移植物抗宿主病发病率相关
Ken Hashimoto,Takahiko Sato,Yuichi Ishikawa et al.
Ken Hashimoto et al.
Acute graft-versus-host disease (GVHD) is one of the serious complications following allogeneic hematopoietic stem cell transplantation (HSCT) that leads to non-relapse mortality. Although several biomarkers for acute GVHD have been propose...
Natural killer cells, macrophages and dendritic cells as innate immune therapies for blood cancers [0.03%]
自然杀伤细胞、巨噬细胞和树突状细胞在血液系统恶性肿瘤免疫治疗中的应用
Ghaleb Oriquat,Waleed K Abdulsahib,Sajida Hussein Ismael et al.
Ghaleb Oriquat et al.
Innate immune cells are emerging as powerful allies in the fight against blood cancers. Natural Killer (NK) cells, macrophages, and dendritic cells (DCs)—once viewed mainly as supporting players—are now at the forefront of next-generation...
Optimizing pediatric ITP therapy: a real-world study on plasma concentration-guided eltrombopag dosing [0.03%]
基于血药浓度调整艾曲波帕剂量治疗儿科ITP患者的疗效观察研究
Jia Li,Bo Liu,Nan Wang et al.
Jia Li et al.
Eltrombopag (ELT) is a second-line therapy for pediatric immune thrombocytopenia (ITP), but inter-individual variability in metabolism leads to wide plasma concentration differences at the same dose, affecting efficacy and adverse drug reac...
GFI1B mutations define an emerging form of inherited thrombocytopenia: insights from a case report and literature review [0.03%]
GFI1B突变定义了一种遗传性血小板减少症的新型形式：一例报告及文献综述的启示
Bartosz Urbański,Katarzyna Bąbol-Pokora,Marcin Braun et al.
Bartosz Urbański et al.
Inherited thrombocytopenias (ITs) constitute a heterogeneous group of congenital bleeding disorders caused by defects in over 50 genes that predominantly affect platelet production. GFI1B has recently emerged as a critical transcriptional r...
A novel HBD gene mutation associated with normal-range hb A2 in β-thalassemia carriers [0.03%]
β-地贫基因携带者血红蛋白A2正常值的新HBD基因突变
Lei Zhang,Jingxin Yang,Xingping Li et al.
Lei Zhang et al.
β-thalassemia is one of the most common single-gene inherited conditions in the world, prevalence of β-thalassaemia in south China is 3–4%,increased Hb A2 level is one of the most important markers of β-thalassemia heterozygous carriers...
Real world outcomes and prognostic factors in Chinese patients with primary mediastinal B cell lymphoma: A single center experience and the Surveillance, Epidemiology, and End Results validation [0.03%]
中国原发纵隔B细胞淋巴瘤患者的临床特征、预后因素及生存分析：单中心经验及SEER数据库验证
Boya Wang,Ruize Chen,Huanhuan Wang et al.
Boya Wang et al.
This study aimed to characterize the clinical characteristics, treatment patterns, survival outcomes, and prognostic factors of Chinese patients with primary mediastinal B-cell lymphoma (PMBCL). We retrospectively reviewed 69 consecutive pa...
A Multi-Omics and machine learning platelet-related prognostic signature in multiple myeloma [0.03%]
多组学和机器学习在多重骨髓瘤血小板相关预后标志物中的应用
Xiaojing Li,Qirong Xiao,Kuangfei Wang et al.
Xiaojing Li et al.
While platelets are well-documented contributors to tumorigenesis, their role in multiple myeloma (MM) progression and risk stratification remains underexplored. To assess platelet function in MM and verify the prognostic value of platelet-...
Emicizumab in the treatment of acquired hemophilia A: A Two-Center experience [0.03%]
艾米西珠单抗治疗获得性血友病A的疗效及安全性：两项中心的经验总结
Malcolm Su,Sean Yates,Melissa Sanchez et al.
Malcolm Su et al.
Emicizumab is a FVIII mimetic antibody used in the treatment of inherited hemophilia A that could potentially be used in acquired hemophilia A (AHA) to achieve hemostasis and shorten hospital stay while reducing bypass therapies. We report ...
Multicenter Study
Annals of hematology. 2026 Feb 28;105(4):150. DOI:10.1007/s00277-026-06905-5 2026
Low hemoglobin as a novel prognostic biomarker in EBV-positive diffuse large B-cell lymphoma patients: a clinical feature analysis of 99 cases from Zhejiang, Southeast China [0.03%]
低血红蛋白作为预测中国东南部99例EB病毒阳性弥漫大B细胞淋巴瘤患者的预后生物标志物：临床特征分析
Mengmeng Huang,Kesang Li,Fang Yu et al.
Mengmeng Huang et al.
Epstein-Barr virus-positive diffuse large B-cell lymphoma (EBV+DLBCL) is a rare and clinically aggressive subtype of DLBCL, distinguished by its notably unfavorable prognosis. The clinical characteristics of this entity remain insufficientl...
Determination of mean corpuscular haemoglobin cut-off point for differentiating alpha plus and alpha zero thalassaemia in thalassaemia screening [0.03%]
用于地中海贫血筛查的α+-型和α0-型地贫区分化的平均红细胞血红蛋白量临界值确定研究
Ezalia Esa,Lailatul Hadziyah Mohd Pauzy,Hafizah Hashim et al.
Ezalia Esa et al.
This study assesses haematological parameters as screening tools for identifying α zero (α⁰) thalassaemia candidates for DNA analysis. The Malaysia Thalassaemia Diagnosis Code (MTDC) uses mean corpuscular haemoglobin (MCH) < 25 pg to scr...